ADF focuses on preventing the harms associated with illicit drugs and alcohol in Australia.
Our membership has been growing organically since IDPC was set up in 2006. Members can be NGOs, academic institutions, think tanks or professional networks, but they must have a national or international outlook, and a credible track record in the drug policy field.
There are no membership fees, but all members need to be committed to supporting the IDPC vision and mission, strategic directions, policy principles and work plan.
IDPC has two types of membership:
IDPC Partner Members
Partner Members are organisations that play a more active role in IDPC’s day-to-day work. These members have the skills, capacity and contacts to engage governments and international organisations on drug policy reform. This level of membership includes clear expectations in terms of involvement in consultations, efficient communication and contribution to the advocacy work. As a result, the selection of Partner Members will be based on the level of engagement of the organisation in IDPC’s work, geographical representation (with no more than one Partner Member per country in most cases), and thematic relevance.
IDPC Network Members
Network Members are organisations that are mostly involved in IDPC’s communications work at a less intensive level. These members receive all IDPC communications, and are involved in exchange of ideas and information, and joint planned activities. These members will be able to use the IDPC alerts and website to promote their work, and will help share IDPC’s news, publications and products with their own contacts. IDPC will usually welcome organisations as Network Members in the first instance, rather than as Partner Members.
Drug Policy Australia is a Non-Governmental Organisation dedicated to promoting harm reduction and evidence-based drug policy in Australia.
Harm Reduction Australia (HRA) is a national organisation for individuals committed to reducing the health, social and economic harms potentially associated with drug use.
Penington Institute actively supports the adoption of approaches to drug use which promote safety and human dignity.
Uniting’s Fair Treatment campaign confronts stigma, develops grassroots leaders and helps lawmakers to better understand and follow the evidence to modernise our drug laws. Uniting also manages the Medically Supervised Injection Centre (MSIC) in Kings Cross, Sydney, Australia. For more information, please visit uniting.org and fairtreatment.org